OICHARTS
8 AMThe 8 AM report →

FISCHER

Fischer Medical Ventures Limited · NSE · INE771F01041 · 272 sessions on record
₹33.46▼ −0.09 · −0.3%from ₹33.55 the session before · 1 Oct 2026 close · NSE end of day
Open
₹34.39
High
₹34.39
Low
₹32.61
Day's range
₹1.85.3% of the previous close
VWAP
₹33.29close +0.51% from it
Volume, shares
2.2 L0.21× the 20-session average
Turnover, ₹ crore
0.73
Trades
1,400160 shares per trade
Previous close
₹33.55−0.09 to the close
Price band, next session
₹30.10 – ₹36.8010% either side of the close · dynamic, widened in 5% steps when hit
Day range48% of the way up
₹32.61₹34.39
52-week range3% of the way up
₹31.05 9 Jun₹121.70 29 Oct

−73% from the high · +7.8% from the low

Futures and options

No derivatives listed on FISCHER

Close ₹ · Nifty 50 rebased to the first close · futures open interest by the day's build-up126 sessions to 1 Oct · axis fixed at 4 × ATR-14 around the last close
272 sessions on file · from 28 Aug
FISCHER close and futures open interest over the last 126 sessions, with Nifty 50 rebased to the first close25.3935.1844.97axis spans 77%Nifty 50FISCHER1 Apr6 Jul1 Oct126 sessions from 1 Apr to 1 Oct; the price axis spans 77 percent.

Quarterly results

consolidated · latest filed 14 Aug, 08:43 pm IST · NSE filings

Revenue ₹82 cr; profit ₹4 cr in the Jun 2026 quarter, consolidated.

Last 2 quarters, consolidated₹ crore as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, Nifty 50 over the same session
Quarterly results of FISCHER on the consolidated basis with the market's move on the first session after each filing
QuarterRevenue ₹ crRevenue YoYProfit ₹ crProfit YoYEPS ₹Market on the day
Jun 2026filed 14 Aug₹82 cr—₹4 cr—0.05▼ −3.5%Nifty −0.3% · −3.2 pp
Mar 2026filed 31 May · audited₹98 cr—−₹7 cr—0.10▼ −5.0%Nifty −0.7% · −4.3 pp

Fundamentals

consolidated · filings to Jun 2026 · close ₹33.46 on 1 Oct

5.7 times book value, a 0.30% dividend yield, market cap ₹2,200 cr.

Valuationarithmetic on filings and the close · each cell names what it rests on · — where an input is missing
Market cap
₹2,200 cron 1 Oct · free float ₹810 cr
Price to earnings
—fewer than four consecutive quarters filed
Trailing EPS
—fewer than four consecutive quarters filed
Price to book
5.7consolidated · balance sheet to Mar 2026
Book value a share
₹5.88consolidated · balance sheet to Mar 2026 · over NSE's share count
Debt to equity
0.19borrowings over equity · consolidated · balance sheet to Mar 2026
Return on equity
—needs two filed balance sheets
Dividend yield
0.30%₹0.10 a share in 365 days
Face value
₹1a share
Shares outstanding
65 cron 1 Oct
Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · consolidated
Revenue, trailing 12 months
—fewer than four consecutive quarters filed
Revenue growth, 12 months
—needs eight consecutive quarters filed
Revenue 3-year CAGR
—needs twelve consecutive quarters filed
Profit, trailing 12 months
—fewer than four consecutive quarters filed
Profit growth, 12 months
—needs eight consecutive quarters filed
Profit 3-year CAGR
—needs twelve consecutive quarters filed
PeersBSE sub-group Medical Equipment & Supplies · F&O stocks with filings on record · industry P/E needs two stocks with trailing profit and a market cap
Stocks in the BSE sub-group Medical Equipment & Supplies with market cap, price to earnings and price to book
StockMarket cap ₹P/EP/BClose ₹
MOLBIOMolbio Diagnostics Limited17,000 cron 1 Oct——₹1,513.10
POLYMEDPoly Medicure Limited17,000 cron 1 Oct—5.3₹1,638.10
FISCHERFischer Medical Ventures Limited2,200 cron 1 Oct—5.7₹33.45
TARSONSTarsons Products Limited1,800 cron 1 Oct—2.8₹329.40
LAXMIDENTLLaxmi Dental Limited1,100 cron 1 Oct—4.4₹193.85
FABTECHFabtech Technologies Limited630 cron 1 Oct—1.5₹142.00
GKBGKB Ophthalmics Limited32 cron 1 Oct——₹64.35
NURECANureca Limited————

Shareholding

quarter to 17 Aug · 6.8% of the promoter holding pledged · NSE filings

Promoters hold 63.1%, foreign portfolio investors 5.6%, banks and financial institutions 1.3% and individual investors 24.1%, as filed for the quarter to 17 Aug.

By category, last 3 quarterspercent of shares · beneath each figure, the change in percentage points against the previous quarter on file
Shareholding of FISCHER by category over the last 3 quarters with the change against the previous quarter
Category17 Aug30 Jun31 Mar
Promoters63.08▲ +0.93 pp62.150.00 pp62.15
Foreign portfolio investors5.57▲ +0.09 pp5.48▲ +0.51 pp4.97
Banks and financial institutions1.26▼ −0.09 pp1.35▼ −0.03 pp1.38
Individual investors24.12▼ −0.52 pp24.64▼ −0.58 pp25.22
Bodies corporate4.13▼ −0.28 pp4.41▲ +0.04 pp4.37
Others1.84▼ −0.13 pp1.97▲ +0.05 pp1.92

Corporate actions

NSE and BSE records

Nothing upcoming on record; the last was a dividend of ₹0.05 a share, ex-date 22 Sept 2026.

Actionsex-dates · upcoming first, then the last eight · dividends in rupees a share, bonus and split as ratios
Corporate actions of FISCHER, upcoming first, then the most recent
Ex-dateActionAmount or ratioRecord dateSource
recent
22 Sept 2026dividend₹0.0522 Sept 2026PR
22 Sept 2025dividend₹0.0122 Sept 2025NSE
12 Sept 2025split—12 Sept 2025NSE
Calendaras notified to the exchange
Next results
—no board meeting notified yet
Dividends in 365 days
₹0.10a share · ex-dates inside the year
Last dividend
₹0.05ex-date 22 Sept 2026

Price history

272 sessions on record · to 1 Oct · NSE end of day

FISCHER is −11.3% over 20 sessions against Nifty's −6.2%, 73% below its 52-week high, realised volatility 35% annualised.

Returns against Nifty 50longest window first · Nifty 50 over the same sessions
Returns of the stock and Nifty 50 over six windows, longest first
WindowFrom ₹FISCHER %Nifty 50 %Difference pp
250 sessionssince 26 Sept₹113.81▼ −71%▼ −9.1%−62
120 sessionssince 9 Apr₹41.04▼ −18%▼ −5.7%−13
60 sessionssince 8 Jul₹37.13▼ −9.9%▼ −6.1%−3.8
20 sessionssince 2 Sept₹37.73▼ −11%▼ −6.2%−5.1
5 sessionssince 24 Sept₹34.23▼ −2.2%▼ −2.8%+0.53
1 sessionsince 30 Sept₹33.55▼ −0.27%▼ −0.88%+0.61
Averages of the closeclose against each average
5-session average
₹33.81close −1.0% from it
20-session average
₹34.40close −2.7% from it
50-session average
₹36.34close −7.9% from it
200-session average
₹37.88close −12% from it
Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average
Average true range, 14
₹2.06.0% of the close
Average day's range, 20
₹1.75.2% of the close
Volume against 20 sessions
0.21×2.2 L vs 10 L average
Volatility and co-movement with Nifty 50annualised from daily log returns · counts share one denominator per cell
Realised volatility, 20
35%≈ ±2.2% a session · moved more than that on 5 of 20
Realised volatility, 60
38%≈ ±2.4% a session · moved more than that on 15 of 60
Realised volatility, 250
55%≈ ±3.5% a session · moved more than that on 66 of 250
Beta to Nifty, 60
0.99moved with Nifty on 36 of 60 sessions
Beta to Nifty, 250
0.57moved with Nifty on 139 of 250 sessions
Up and down sessionscloses above and below the previous close
Last 20 sessions
5 up · 15 downof 20
Last 60 sessions
23 up · 37 downof 60
Last 250 sessions
102 up · 147 downof 249
Best session, 250
▲ +9.5%11 Jun
Worst session, 250
▼ −15%11 Nov

0 bulletins on FISCHER

The desk has not written about Fischer Medical Ventures Limited yet. The tape carries every bulletin as it is published.

About Fischer Medical Ventures Limited

exchange masters as of 18 Sept 2026 · classification by BSE
Company
Fischer Medical Ventures Limited
Exchange
NSE · BSE 524743, group B
Listed on NSE
10 Jul 2025
Classification
Healthcare › Healthcare Equipment & Supplies › Medical Equipment & Supplies
Index
BSE 1000
Face value
₹1 a share
ISIN
INE771F01041
Sessions on record
272
Price source
NSE UDiFF bhavcopy · end of day · delayed
Filings
NSE and BSE public disclosures · results, shareholding and corporate actions as filed
Computed
1 Oct, 09:00 pm IST
Bulletins
0 · written by the desk · not a recommendation

OI Charts is not a SEBI-registered investment adviser or research analyst. Prices, open interest, filings and the desk read are exchange data and arithmetic on it, not a basis for any investment decision.